Mirati Therapeutics, Inc. MRTX
58.70 +58.70
Day range unavailable
52-week range unavailable
MRTX revenue history
Revenue is income from the company’s ordinary business activities.
12,436,000 USD
FY 2022 · Period ended
Coverage: stale. Values in USD; not inflation adjusted.
Reporting currency is USD by the source’s USD conversion factor of 1; the source does not name the currency.
Scroll the table to see all values →
| Fiscal period | Period end | Revenue | YoY change | YoY % |
|---|---|---|---|---|
| FY 2022 | 2022-12-31 | 12,436,000 | -59,656,000 | -82.75% |
| FY 2021 | 2021-12-31 | 72,092,000 | 58,694,000 | 438.08% |
| FY 2020 | 2020-12-31 | 13,398,000 | 10,063,000 | 301.74% |
| FY 2019 | 2019-12-31 | 3,335,000 | -9,591,000 | -74.20% |
| FY 2018 | 2018-12-31 | 12,926,000 | 12,926,000 | Not meaningful |
| FY 2017 | 2017-12-31 | 0 | 0 | Not meaningful |
| FY 2016 | 2016-12-31 | 0 | 0 | Not meaningful |
| FY 2015 | 2015-12-31 | 0 | 0 | Not meaningful |
| FY 2014 | 2014-12-31 | 0 | 0 | Not meaningful |
| FY 2013 | 2013-12-31 | 0 | 0 | Not meaningful |
| FY 2012 | 2012-12-31 | 0 | -3,144,000 | -100.00% |
| FY 2011 | 2011-12-31 | 3,144,000 | Not available | Not available |
Percentage growth is shown only when the same fiscal period one year earlier has a positive value. Missing periods are not estimated.
Company-reported financial statements. Retrieved 2025-01-04T21:03:14.000Z. Retrieval time is not a report date.
Open full statementsUse Add to watchlist above to save this stock.